StonvexLoading…
StonvexStonvexStonvexCore line items from NFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $573.56M | $1.55B | $637.86M | $2.22B | $1.78B |
Operating Income | Not available | $623.26M | $276.12M | $813.46M | $633.69M |
Net Income | Not available | $429.31M | $181.65M | $518.50M | $411.16M |
EPS (Diluted) | $1.48 | $4.58 | $1.98 | $5.68 | $4.51 |
Total Assets | Not available | $9.13B | $9.21B | $8.72B | $8.45B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $26.60M | $271.40M | $43.17M | $39.32M |
Free Cash Flow OCF − CapEx | Not available | $159.01M | $-2.71M | $187.21M | $234.96M |
Shares Outstanding | Not available | 95.03M | 95.02M | 90.38M | 90.36M |